Kelly D DeMarco

5PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 21, 2026
Senolytic Interventions Enhance the Anti-metastatic Activity of Chemotherapy in Prostate Cancer.

|Oct 24, 2025
p21-Positive Senescent Stromal Cells Promote Prostate Cancer Immune Suppression and Progression That Can Be Reversed by Senolytic Therapy.

Lin Zhou, Kelly D DeMarco, Katherine C Murphy

|Sep 03, 2025
MYC and p53 Alterations Cooperate through VEGF Signaling to Repress Cytotoxic T-cell and Immunotherapy Responses in Prostate Cancer.

Katherine C Murphy, Kelly D DeMarco, Lin Zhou

|Aug 28, 2024
Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancer.

Loretah Chibaya, Kelly D DeMarco, Christina F Lusi

|Aug 02, 2024
MYC and p53 alterations cooperate through VEGF signaling to repress cytotoxic T cell and immunotherapy responses in prostate cancer.

Katherine C Murphy, Kelly D DeMarco, Lin Zhou

Pageof 1

Frequent Collaborators

5 joint publications

Katherine C Murphy

5 joint publications

Lihua Julie Zhu

5 joint publications

Marcus Ruscetti

4 joint publications

Lin Zhou